165 related articles for article (PubMed ID: 1987493)
1. Immunosuppressive acidic protein and CA 125 levels in patients with ovarian cancer.
Castelli M; Battaglia F; Scambia G; Panici PB; Ferrandina G; Mileo AM; Mancuso S; Ferrini U
Oncology; 1991; 48(1):13-7. PubMed ID: 1987493
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
Koebl H; Tatra G; Bieglmayer C
Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive acidic protein (IAP) and CA 125 assays in detection of human ovarian cancer: preliminary results.
Castelli M; Romano P; Atlante G; Pozzi M; Ferrini U
Int J Biol Markers; 1987; 2(3):187-90. PubMed ID: 3482661
[TBL] [Abstract][Full Text] [Related]
4. ["Immunosuppressive acidic protein" (IAP)--an improvement for tumor marker diagnosis in epithelial ovarian cancer?].
Sevelda P; Haider F; Spona J
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):452-5. PubMed ID: 3476335
[TBL] [Abstract][Full Text] [Related]
5. Alpha 1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125.
Mogensen O; Mogensen B; Jakobsen A
Cancer; 1989 Nov; 64(9):1867-71. PubMed ID: 2477138
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of immunosuppressive acidic protein in human ovarian cancer.
Lin YH; Chow SN; Chen CK; Chen RJ; Huang SC; Huang GT
J Formos Med Assoc; 1994 Sep; 93(9):776-80. PubMed ID: 7735007
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive acidic protein in patients with ovarian cancer.
Sawada M; Okudaira Y; Matsui Y; Shimizu Y
Cancer; 1983 Dec; 52(11):2081-5. PubMed ID: 6627216
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian cancer--a comparison between CT diagnosis and serum tumor markers].
Wakabayashi Y; Yachida M; Akata S; Kawana K; Kotake F; Kakizaki D; Abe K; Negishi N; Akiya K
Gan No Rinsho; 1988 Jan; 34(1):52-6. PubMed ID: 3422324
[TBL] [Abstract][Full Text] [Related]
9. Elevation of multiple serum markers in patients with stage I ovarian cancer.
Woolas RP; Xu FJ; Jacobs IJ; Yu YH; Daly L; Berchuck A; Soper JT; Clarke-Pearson DL; Oram DH; Bast RC
J Natl Cancer Inst; 1993 Nov; 85(21):1748-51. PubMed ID: 8411259
[TBL] [Abstract][Full Text] [Related]
10. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive acidic protein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
[TBL] [Abstract][Full Text] [Related]
12. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
[TBL] [Abstract][Full Text] [Related]
13. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
14. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
15. [Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings].
Meden H; Rath W; Teichmann A; Kuhn W
Onkologie; 1989 Oct; 12(5):217-20. PubMed ID: 2685687
[TBL] [Abstract][Full Text] [Related]
16. CA 15-3 serum levels in ovarian cancer.
Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
[TBL] [Abstract][Full Text] [Related]
17. [Significance of immunosuppressive acidic protein in the diagnosis and follow-up of patients with ovarian cancer, in particular as a marker for chemotherapeutic effects].
Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):554-60. PubMed ID: 3701144
[TBL] [Abstract][Full Text] [Related]
18. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker.
Onetto M; Bruzzone M; Conte PF; Ruvolo M; Conio A; Chiara S; Falcone A; Bentivoglio G; Serra GE; Paganuzzi M
Oncology; 1989; 46(2):117-22. PubMed ID: 2710476
[TBL] [Abstract][Full Text] [Related]
20. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
